4 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow Methamphetamine Use Disorder: new trials by email Literature Review of Methamphetamine Use Disorder trials Research Report on Methamphetamine Use Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV Ketamine, Psychotherapy - Methamphetamine Use Disorder | Phase 2 | Completed | Nicky Mehtani, MD, MPH | 17 | 2025-03-04 | 2026-08-12 |
| Tirzepatide for Obesity and Meth Use Disorder Tirzepatide - Obesity, Methamphetamine Use Disorder | Phase 2 | Completed | University of Texas Southwestern Medical Center | 35 | 2025-02-03 | 2026-09-28 |
| Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM Naltrexone Hydrochloride, Placebo, Ecological Momentary Intervention - Methamphetamine Use Disorder | Phase 2 | Completed | Glenn-Milo Santos | 60 | 2021-12-14 | 2025-10-27 |
| Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder naltrexone plus bupropion - Methamphetamine Use Disorder | Phase 1 / Phase 2 | Completed | Walter Ling | 49 | 2013-11-01 | 2020-03-23 |
Chemsex (1) · Obesity (1) · Overweight (1) · Sexual Behavior (1)
Behavior (1) · Body Weight (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Naltrexone (2) · Bupropion (1) · Ketamine (1) · Psychotherapy (1) · Therapeutics (1) · Tirzepatide (1)
Glenn-Milo Santos (1) · Nicky Mehtani, MD, MPH (1) · University of Texas Southwestern Medical Center (1) · Walter Ling (1)
United States (4)
Glenn-Milo Santos, PhD, MPH (1) · Larissa Mooney, M.D. (1) · Manish Jha, M.B.B.S. (1) · Nicky Mehtani, MD MPH (1) · Walter Ling, M.D. (1)
2KL2TR001870 (1), R01DA053171 (1), U10DA013045 (1)